CareDx, Inc (CDNA)
USD 15.0
(-0.46%)
USD 15.0
(-0.46%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 19.47 Million USD | 1.24% |
| 2022 | 19.23 Million USD | 11.91% |
| 2021 | 17.18 Million USD | 71.65% |
| 2020 | 10.01 Million USD | 66.48% |
| 2019 | 6.01 Million USD | 21.67% |
| 2018 | 4.94 Million USD | -10.6% |
| 2017 | 5.52 Million USD | 1.25% |
| 2016 | 5.46 Million USD | 612.92% |
| 2015 | 766 Thousand USD | 11.66% |
| 2014 | 686 Thousand USD | 32.43% |
| 2013 | 518 Thousand USD | -10.07% |
| 2012 | 576 Thousand USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 19.23 Million USD | -4.45% |
| 2024 Q3 | 19.26 Million USD | 0.15% |
| 2024 Q1 | 20.13 Million USD | 3.38% |
| 2023 Q1 | 18.01 Million USD | -6.31% |
| 2023 Q3 | 17.97 Million USD | -4.58% |
| 2023 Q2 | 18.84 Million USD | 4.56% |
| 2023 FY | 19.47 Million USD | 1.24% |
| 2023 Q4 | 19.47 Million USD | 8.3% |
| 2022 Q2 | 18.86 Million USD | 3.56% |
| 2022 Q1 | 18.21 Million USD | 5.97% |
| 2022 FY | 19.23 Million USD | 11.91% |
| 2022 Q4 | 19.23 Million USD | 6.34% |
| 2022 Q3 | 18.08 Million USD | -4.11% |
| 2021 Q4 | 17.18 Million USD | -8.59% |
| 2021 Q2 | 15.06 Million USD | 9.76% |
| 2021 Q3 | 18.8 Million USD | 24.83% |
| 2021 FY | 17.18 Million USD | 71.65% |
| 2021 Q1 | 13.72 Million USD | 37.05% |
| 2020 Q2 | 8.74 Million USD | 25.82% |
| 2020 FY | 10.01 Million USD | 66.48% |
| 2020 Q4 | 10.01 Million USD | 1.07% |
| 2020 Q1 | 6.94 Million USD | 15.51% |
| 2020 Q3 | 9.9 Million USD | 13.33% |
| 2019 Q2 | 5.34 Million USD | 3.17% |
| 2019 Q4 | 6.01 Million USD | 1.9% |
| 2019 FY | 6.01 Million USD | 21.67% |
| 2019 Q3 | 5.9 Million USD | 10.5% |
| 2019 Q1 | 5.17 Million USD | 4.73% |
| 2018 Q4 | 4.94 Million USD | 6.97% |
| 2018 Q3 | 4.62 Million USD | -0.96% |
| 2018 Q2 | 4.66 Million USD | -6.88% |
| 2018 Q1 | 5.01 Million USD | -9.37% |
| 2018 FY | 4.94 Million USD | -10.6% |
| 2017 FY | 5.52 Million USD | 1.25% |
| 2017 Q4 | 5.52 Million USD | -10.39% |
| 2017 Q3 | 6.17 Million USD | -2.73% |
| 2017 Q2 | 6.34 Million USD | 4.88% |
| 2017 Q1 | 6.04 Million USD | 10.75% |
| 2016 Q3 | 7.44 Million USD | -15.9% |
| 2016 Q4 | 5.46 Million USD | -26.64% |
| 2016 FY | 5.46 Million USD | 612.92% |
| 2016 Q1 | 595 Thousand USD | -22.32% |
| 2016 Q2 | 8.85 Million USD | 1387.56% |
| 2015 Q3 | 814 Thousand USD | 11.35% |
| 2015 Q2 | 731 Thousand USD | -5.68% |
| 2015 FY | 766 Thousand USD | 11.66% |
| 2015 Q1 | 775 Thousand USD | 12.97% |
| 2015 Q4 | 766 Thousand USD | -5.9% |
| 2014 Q4 | 686 Thousand USD | 38.31% |
| 2014 Q3 | 496 Thousand USD | -19.22% |
| 2014 Q2 | 614 Thousand USD | -15.31% |
| 2014 Q1 | 725 Thousand USD | 39.96% |
| 2014 FY | 686 Thousand USD | 32.43% |
| 2013 Q1 | - USD | 0.0% |
| 2013 FY | 518 Thousand USD | -10.07% |
| 2013 Q4 | 518 Thousand USD | 0.0% |
| 2012 FY | 576 Thousand USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | - USD | -Infinity% |
| Biodesix, Inc. | 1.4 Million USD | -1290.786% |
| bioAffinity Technologies, Inc. | 18.48 Thousand USD | -105239.753% |
| Castle Biosciences, Inc. | 7.94 Million USD | -145.165% |
| DarioHealth Corp. | 5.06 Million USD | -284.65% |
| Exact Sciences Corporation | 127.47 Million USD | 84.726% |
| IDEXX Laboratories, Inc. | 380.28 Million USD | 94.88% |
| Illumina, Inc. | 587 Million USD | 96.683% |
| Intelligent Bio Solutions Inc. | 777.53 Thousand USD | -2404.19% |
| iSpecimen Inc. | - USD | -Infinity% |
| Standard BioTools Inc. | 20.53 Million USD | 5.172% |
| 23andMe Holding Co. | 12.46 Million USD | -56.205% |
| Medpace Holdings, Inc. | 1.00 USD | -1947099900.0% |
| NeoGenomics, Inc. | 24.15 Million USD | 19.395% |
| Inotiv, Inc. | 56.1 Million USD | 65.294% |
| Psychemedics Corporation | 1.00 USD | -1947099900.0% |
| Prenetics Global Limited | 3.12 Million USD | -522.718% |
| Precipio, Inc. | 384 Thousand USD | -4970.573% |
| RadNet, Inc. | 1.00 USD | -1947099900.0% |
| Sotera Health Company | 51.98 Million USD | 62.545% |
| Star Equity Holdings, Inc. | 3.42 Million USD | -469.327% |
| Exagen Inc. | 2.87 Million USD | -578.196% |
| Natera, Inc. | 40.75 Million USD | 52.229% |
| Aspira Women's Health Inc. | 227 Thousand USD | -8477.533% |
| Neogen Corporation | 189.26 Million USD | 89.712% |
| Myriad Genetics, Inc. | 20.1 Million USD | 3.129% |
| ICON Public Limited Company | 1.00 USD | -1947099900.0% |
| Bionano Genomics, Inc. | 22.89 Million USD | 14.948% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Twist Bioscience Corporation | 32.06 Million USD | 39.273% |
| Guardant Health, Inc. | 61.94 Million USD | 68.569% |
| BioNexus Gene Lab Corp. | 1.13 Million USD | -1611.33% |
| Fulgent Genetics, Inc. | 5.82 Million USD | -234.151% |
| Sera Prognostics, Inc. | - USD | -Infinity% |
| OPKO Health, Inc. | 65.69 Million USD | 70.362% |
| Personalis, Inc. | 5.66 Million USD | -243.95% |
| Applied DNA Sciences, Inc. | 330.02 Thousand USD | -5799.82% |
| Star Equity Holdings, Inc. | 3.42 Million USD | -469.327% |
| MDxHealth SA | 2.77 Million USD | -600.648% |
| Prenetics Global Limited | 3.12 Million USD | -522.718% |
| ENDRA Life Sciences Inc. | 2.62 Million USD | -642.356% |
| Mainz Biomed B.V. | 613.63 Thousand USD | -3073.043% |
| Trinity Biotech plc | 19.93 Million USD | 2.318% |
| Neuronetics, Inc. | 8.09 Million USD | -140.591% |
| bioAffinity Technologies, Inc. | 18.48 Thousand USD | -105239.753% |